UNSPSC 51281815: Carubicin hydrochloride

This classification denotes the hydrochloride form of an anthracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7437K3983. European Medicines Agency schedules Carubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06151MIG. Carubicin generally arises in the molecular formula C26H27NO10.

UNSPSC 51281815 Carubicin hydrochloride is a Commodity code representing a single pharmaceutical product line, but the recent state and local opportunities tagged under this code show minimal alignment with the nominal scope. The two recent records in the dataset reference different pharmaceutical products entirely — one awarded contract covers Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through a cooperative purchasing vehicle, and a second opportunity solicits Naloxone and drug deactivation systems. Neither product is carubicin hydrochloride. State and local health and social-service agencies do procure pharmaceuticals through piggyback contracts tied to established cooperative purchasing consortiums and through direct IFB processes, but the specific activity under this code tag does not reflect the code's stated commodity.

The issuing bodies in the available records are a state health department (Illinois Department of Public Health) and a county government (Seminole County, Florida). The Illinois contract, awarded to Chartwell Rx LLC on August 28, 2026, was a $2,999,999.11 piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium with an initial 12-month term and two optional renewal years. The Seminole County IFB, posted June 30, 2026 with a response deadline of July 26, 2023 (a date inconsistency in the source), sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. No set-aside designations or disadvantaged-enterprise preferences were cited in either record. The code shows little recent activity directly aligned to carubicin hydrochloride procurement.